Stockscreener 앱 받기
102.02
15.36%
-18.52
Biontech Se Adr 주식(BNTX)의 최신 뉴스
Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today - The Motley Fool
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? - Yahoo Finance
BioNTech SE ADR [BNTX] Shares Jump Approximately 32.28% Over the Year - knoxdaily.com
Today’s watch list includes BioNTech SE ADR (NASDAQ:BNTX) stock - uspostnews.com
AMKOR Technology Inc [AMKR] Records 200-Day SMA of $26.99 - knoxdaily.com
Fluence Energy Inc [FLNC] Officer makes an insider purchase of 78,258 shares worth 0.29 million. - knoxdaily.com
Immunovant Inc [IMVT] Records 50-Day SMA of $18.03 - knoxdaily.com
It makes sense and dollars to buy BioNTech SE ADR (BNTX) stock - Sete News
Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains? - Yahoo Finance
BioNTech Surges On Summit's Coattails. But Can They Take On Merck? - Investor's Business Daily
Stocks With Rising Relative Strength: BioNTech ADR - Investor's Business Daily
BioNTech, Pfizer report good news from vaccine trial - Morningstar
Strength Seen in BioNTech (BNTX): Can Its 6.0% Jump Turn into More Strength? - Yahoo Finance
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? - Yahoo Finance
Pfizer Stock Falls To New 52-Week Low: Should You Buy The Dip? - Barchart.com
CureVac’s amended patent upheld by European Patent Office - Investing.com
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
BioNTech’s Earnings Call: Oncology Growth Amidst Challenges - TipRanks
BioNTech’s 2024 Earnings Highlight Oncology Focus - TipRanks
BioNTech Earnings: 2025 Guidance Disappoints, Fair Value Lowered - Morningstar
BioNTech's mRNA Technology and Acquired Oncology Programs Could Support a Future Moat - Morningstar
Jefferies maintains BioNTech stock Buy rating, $149 target - Investing.com India
BioNTech Q4 earnings beat, but stock falls 3% on weak 2025 outlook - Investing.com
Earnings call transcript: BioNTech beats Q4 2024 expectations, stock dips - Investing.com
US Stocks Likely To Open Lower After Trump Hints At Looming Recession: Expert Says Can't Rule Out A Bear Market As Indices Inch Towards Correction Territory - Benzinga
BioNTech reports Q4 EPS EUR 1.08 vs. EUR 1.88 last year - TipRanks
Here's Why Moderna Stock Soared 16% On Wednesday - Barchart
Here's Why Moderna Stock Soared 16% on Wednesday - Yahoo Finance
BioNTech SE's RNA-based vaccine for malaria placed on clinical hold by FDA - MSN
Paramount Group Inc (PGRE) Shares Soar Above 1-Year High - The News Heater
Pfizer and BioNTech violated COVID-19 vaccine patent held by Moderna, German court rules - The Globe and Mail
BioNTech stock falls after FDA clinical hold on malaria vaccine trial - Investing.com
BioNTech SEADR to Host Earnings Call - ACCESS Newswire
Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus - Yahoo Finance
AASTOCKS Financial NewsBioNTech SE (BNTX) - AASTOCKS.com
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - MSN
What Makes BioNTech (BNTX) a New Buy Stock - Yahoo Finance UK
BioNTech SE ADR (BNTX) did well last session? - US Post News
Electronic Arts Posts Upbeat Earnings, Joins Mattel, Johnson Controls, Mueller Water Products And Other Big Stocks Moving Higher On WednesdayBloom Energy (NYSE:BE), BigBear.ai Hldgs (NYSE:BBAI) - Benzinga
Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales - Barchart
Moderna and BioNTech shares fall after Senate committee vote on RFK Jr. - Investing.com
Hesai Group ADR (HSAI) shows promising results - US Post News
Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings? - Yahoo Finance
Will Non-COVID Drugs Drive PFE's Top Line In Q4 Earnings? - Barchart.com
Validea Benjamin Graham Strategy Daily Upgrade Report1/31/2025 - Nasdaq
BioNTech's SWOT analysis: oncology pipeline, cash boost stock outlook - Investing.com
Stocks To Watch: BioNTech ADR Sees Relative Strength Rating Rise To 84 - Investor's Business Daily
4.40%
3.69%
자본화:
|
볼륨(24시간):